IQGAP2, A candidate tumour suppressor of prostate tumorigenesis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 6, 2012, Pages 875-884

  Xie, Yanyun ^a,b,c,d,e   Yan, Judy ^a,b,c,d   Cutz, Jean Claude ^b   Rybak, Adrian P ^a,b,c,d   He, Lizhi ^a,b,c,d   Wei, Fengxiang ^a,b,c,d,f   Kapoor, Anil ^b,c,d   Schmidt, Valentina A ^g   Tao, Lijian ^e   Tang, Damu ^a,b,c,d  

^a Division of Nephrology   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d ST JOSEPH S HOSPITAL   (Canada)

^e CENTRAL SOUTH UNIVERSITY   (China)

^f Institute of Women and Children's Health   (China)

^g STONY BROOK UNIVERSITY   (United States)

Author keywords

AKT; EMT; IQGAP2; Prostate cancer; Tumour suppressor

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 2; PROTEIN KINASE B; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CELL STRAIN LNCAP; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CADHERINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RAS GTPASE-ACTIVATING PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

EID: 84858966778     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.02.019     Document Type: Article

References (51)

1. Briggs M.W., Sacks D.B. IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep. 2003, 4:571-574.
2. White C.D., Brown M.D., Sacks D.B. IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett. 2009, 583:1817-1824.
3. Brill S., Li S., Lyman C.W., Church D.M., Wasmuth J.J., Weissbach L., Bernards A., Snijders A.J. The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases. Mol. Cell. Biol. 1996, 16:4869-4878.
4. Sun W., Zhang K., Zhang X., Lei W., Xiao T., Ma J., Guo S., Shao S., Zhang H., Liu Y., Yuan J., Hu Z., Ma Y., Feng X., Hu S., Zhou J., Cheng S., Gao Y. Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization. Cancer Lett. 2004, 212:83-93.
5. Bertucci F., Salas S., Eysteries S., Nasser V., Finetti P., Ginestier C., Charafe-Jauffret E., Loriod B., Bachelart L., Montfort J., Victorero G., Viret F., Ollendorff V., Fert V., Giovaninni M., Delpero J.R., Nguyen C., Viens P., Monges G., Birnbaum D., Houlgatte R. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 2004, 23:1377-1391.
6. Hart M.J., Callow M.G., Souza B., Polakis P. IQGAP1, a calmodulin-binding protein with a rasGAP-related domain, is a potential effector for cdc42Hs. EMBO J. 1996, 15:2997-3005.
7. Swart-Mataraza J.M., Li Z., Sacks D.B. IQGAP1 is a component of Cdc42 signaling to the cytoskeleton. J. Biol. Chem. 2002, 277:24753-24763.
8. Jadeski L., Mataraza J.M., Jeong H.W., Li Z., Sacks D.B. IQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cells. J. Biol. Chem. 2008, 283:1008-1017.
9. Osman M. An emerging role for IQGAP1 in regulating protein traffic. Sci. World J. 2010, 10:944-953.
10. Jin S.H., Akiyama Y., Fukamachi H., Yanagihara K., Akashi T., Yuasa Y. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells. Int. J. Cancer 2008, 122:1040-1046.
11. Schmidt V.A., Chiariello C.S., Capilla E., Miller F., Bahou W.F. Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. Mol. Cell. Biol. 2008, 28:1489-1502.
12. White C.D., Khurana H., Gnatenko D.V., Li Z., Odze R.D., Sacks D.B., Schmidt V.A. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. BMC Gastroenterol. 2010, 10:125.
13. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics. Cancer J Clin. 2007, 57:43-66.
14. Williams H., Powell I.J. Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Methods Mol. Biol. 2009, 472:439-453.
15. Ross J.S. The androgen receptor in prostate cancer: therapy target in search of an integrated diagnostic test. Adv. Anat. Pathol. 2007, 14:353-357.
16. Moon C., Park J.C., Chae Y.K., Yun J.H., Kim S. Current status of experimental therapeutics for prostate cancer. Cancer Lett. 2008, 266:116-134.
17. Lozano J.J., Soler M., Bermudo R., Abia D., Fernandez P.L., Thomson T.M., Ortiz A.R. Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data. BMC Genomics 2005, 6:109.
18. Tamura K., Furihata M., Tsunoda T., Ashida S., Takata R., Obara W., Yoshioka H., Daigo Y., Nasu Y., Kumon H., Konaka H., Namiki M., Tozawa K., Kohri K., Tanji N., Yokoyama M., Shimazui T., Akaza H., Mizutani Y., Miki T., Fujioka T., Shuin T., Nakamura Y., Nakagawa H. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. Cancer Res. 2009, 69:8133-8140.
19. Hayward S.W., Dahiya R., Cunha G.R., Bartek J., Deshpande N., Narayan P. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell. Dev. Biol. Anim. 1995, 31:14-24.
20. Batlle E., Sancho E., Francí C., Domínguez D., Monfar M., Baulida J., García De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2000, 2:84-89.
21. Li Y., Wu D., Chen B., Ingram A., He L., Liu L., Zhu D., Kapoor A., Tang D. ATM activity contributes to the tumor-suppressing functions of p14ARF. Oncogene 2004, 23:7355-7365.
22. He L., Ingram A., Rybak A.P., Tang D. Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. J. Clin. Invest. 2010, 120:2094-2108.
23. Cupit L.D., Schmidt V.A., Miller F., Bahou W.F. Distinct PAR/IQGAP expression patterns during murine development: implications for thrombin-associated cytoskeletal reorganization. Mamm. Genome 2004, 15:618-629.
24. Rybak A.P., He L., Kapoor A., Cutz J.C., Tang D. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochim. Biophys. Acta 2011, 1813:683-694.
25. Patrawala L., Calhoun T., Schneider-Broussard R., Li H., Bhatia S., Tang J.G., Reilly J.G., Chandra D., Zhou J., Claypool K., Coghlan L., Tang D.G. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006, 25:1696-1708.
26. Guarino M., Rubino B., Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007, 39:305-318.
27. Yilmaz M., Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009, 28:15-33.
28. Wu Y., Zhou B.P. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br. J. Cancer 2010, 102:639-644.
29. Peinado H., Ballestar E., Esteller M., Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell. Biol. 2004, 24:306-319.
30. Kim C.J., Sakamoto K., Tambe Y., Inoue H. Opposite regulation of epithelial-to- mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells. Int. J. Oncol. 2011, 38:1759-1766.
31. Kolegraff K., Nava P., Helms M.N., Parkos C.A., Nusrat A. Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β- catenin signaling. Mol. Biol. Cell 2011, 22:1121-1134.
32. Lau M.T., Klausen C., Leung P.C. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression. Oncogene 2011, 30:2753-2766.
33. Sherr C.J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 1998, 12:2984-2991.
34. Clark J.P., Cooper C.S. ETS gene fusions in prostate cancer. Nat. Rev. Urol. 2009, 6:429-439.
35. Narod S.A., Seth A., Nam A. Fusion in the ETS gene family and prostate cancer. Br. J. Cancer 2008, 99:847-851.
36. Richter E., Srivastava S., Dobi A. Androgen receptor and prostate cancer. Prostate Cancer Prostatic Dis. 2007, 10:114-118.
37. Blanco-Aparicio C., Renner O., Leal J.F., Carnero A. PTEN, more than the AKT pathway. Carcinogenesis 2007, 28:1379-1386.
38. Wang S., Gao J., Lei Q., Rozengurt N., Pritchard C., Jiao J., Thomas G.V., Li G., Roy- Burman P., Nelson P.S., Liu X., Prostate-specific H.Wu. deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 2003, 4:209-221.
39. Johnson M., Sharma M., Henderson B.R. IQGAP1 regulation and roles in cancer. Cell. Signal. 2009, 21:1471-1478.
40. Furuta M., Kozaki K.I., Tanaka S., Arii S., Imoto I., Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010, 31:766-776.
41. Fowler A., Thomson D., Giles K., Maleki S., Mreich E., Wheeler H., Leedman P., Biggs M., Cook R., Little N., Robinson B., McDonald K. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur. J. Cancer 2011, 47:953-963.
42. McCallum S.J., Wu W.J., Cerione R.A. Identification of a putative effector for Cdc42Hs with high sequence similarity to the RasGAP-related protein IQGAP1 and a Cdc42Hs binding partner with similarity to IQGAP2. J. Biol. Chem. 1996, 271:21732-21737.
43. Brill S., Li S., Lyman C.W., Church D.M., Wasmuth J.J., Weissbach L., Bernards A., Snijders A.J. The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases. Mol. Cell. Biol. 1996, 16:4869-4878.
44. Kuroda S., Fukata M., Nakagawa M., Fujii K., Nakamura T., Ookubo T., Izawa I., Nagase T., Nomura N., Tani H., Shoji I., Matsuura Y., Yonehara S., Kaibuchi K. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion. Science 1998, 281:832-835.
45. Yamashiro S., Abe H., Mabuchi I. IQGAP2 is required for the cadherin-mediated cell-to-cell adhesion in Xenopus laevis embryos. Dev. Biol. 2007, 308:485-493.
46. Cao J., Chiarelli C., Richman O., Zarrabi K., Kozarekar P., Zucker S. Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. J. Biol. Chem. 2008, 283:6232-6240.
47. Chen F., Zhu H.H., Zhou L.F., Wu S.S., Wang J., Chen Z. IQGAP1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation by Akt activation. Exp. Mol. Med. 2010, 42:477-483.
48. Natale D.R., Watson A.J. Rac-1 and IQGAP are potential regulators of E-cadherin catenin interactions during murine preimplantation development. Gene Expr. Patterns 2002, 2:17-22.
49. Mataraza J.M., Briggs M.W., Li Z., Entwistle A., Ridley A.J., Sacks D.B. IQGAP1 promotes cell motility and invasion. J. Biol. Chem. 2003, 278:41237-41245.
50. Mataraza J.M., Li Z., Jeong H.W., Brown M.D., Sacks D.B. Multiple proteins mediate IQGAP1-stimulated cell migration. Cell. Signal. 2007, 19:1857-1865.
51. Sakurai-Yageta M., Recchi C., Le Dez G., Sibarita J.B., Daviet L., Camonis J., D'Souza-Schorey C., Chavrier P. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J. Cell Biol. 2008, 181:985-998.